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Abstract  
 
Background: Alpinia oxyphylla fruit (AOF, Yizhi in Chinese) is a well-known traditional Chinese medicine as an anti-diuretic agent 
and composed of two parts i.e. seed and shell. These two parts have different components, but the bioactivity differences of the two 
parts are not clear. This study aims to evaluate the different anti-diuretic effects of the seed and shell of AOF.  
Materials and Methods: The potential bioactive components were analyzed by UPLC-Q-TOF-MS. The diuretic and anti-diuretic 
activity was determined with saline-loads rats.  
Results: The results showed that the 200 mg/kg and 400mg/kg of SREAO displayed a short-time anti-diuretic activity 1h after 
administration and then a significant diuretic activity was being observed at 5-6 h in 400mg/kg group of SREAO. And the 400mg/kg 
doses of SREAO also showed a remarkable increase for electrolyte excretion of K+. Three sesquiterpene compounds, namely 
oxyphyllol A (1), oxyphyllol B (2), and nootkatone (3) were identified from the active SREAO fraction by UHPLC-ESI-Q-TOF/MS.  
Conclusion: The seed part of Alpinia oxyphylla possessed pronounced diuretic and anti-diuretic effect. The sesquiterpene 
components are the major constituents and possibly contributed the diuretic and anti-diuretic activity.  
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Introduction 
 
Alpiniae oxyphyllae fructus (AOF, Yizhi in Chinese), the dried fruits of Alpinia oxyphylla Miq. (Zingiberaceae) is widely 
distributed in South-China. AOF is known traditionally to have anti-diuresis and anti-diarrhea action, and has been used for the 
treatment of diarrhea, enuresis and salivation for more than 1000 years (State Administration of traditional Chinese medicine 
“Chinese Maeria Medica” editorial board,1999). Phytochemical investigations showed that crude drug have several kinds of 
components such as sesquiterpenes, diphenylheptanes, flavones and volatiles (Luo et al., 2000; Zhang et al., 1997; Xie et al., 2014; 
Han et al., 2007; Bian et al., 2013). Modern pharmacological investigations have shown that its main compounds of nootkatone, 
yakuchinone A and tectochrysin have various bioactivities, such as anti-diarrhea, anti-inflammation, cardiac apoptosis protective 
effects, anti-ulcer (Zhang et al., 2012; Chang et al., 2013; Zhang et al., 2015; Shi et al., 2015; Xu et al., 2012, 2013; Yu et al., 2013; 
Chen P et al., 2014). 
Our previous research showed the fruits of Alpinia oxyphylla can easily separate into two different parts by knocking i.e. the 
seed and shell. By the UFLC-MSMS analysis we found that the sesquiterpenes is mainly consisted in the seed, while the 
diphenylheptanes existed in the shell of the fruits (Chen F, 2014). Recent pharmacological studies have shown that the fruit can 
reduce the urine volume in the saline-loads rats (Li WB et al., 2013). But the bioactive fractions or the components responsible for 
the anti-diuretic activity and the anti-diuretic mechanism of AOF remain unclear. So the primary aim of this study was to evaluate the 
anti-diuretic effectiveness of two ethanol extracts respectively obtained from the seed (Sesquiterpenes-Rich Extraction, SREAO) and 
the shell (Diphenylheptanes-Rich Extraction, DREAO). In order to clarify the contribution of the different kind of compounds to the 
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anti-diuretic activity of AOF, these two extracts were orally administrated to the rat. And then the urine excretion rate, pH and 
electrolyte excretion were measured in normal rats. The chemical constituents of the anti-diuretic SREAO fractions were analyzed by 
the method of UHPLC-Q-TOF/MS. 
 
Materials and Methods 
Materials 
 
AOF was collected from Qiongzhong County, Hainan Province in June 2014, and was identified by Prof. Y.B. Li (Hainan 
Medical University, Haikou, Hainan, China). A voucher specimen (HY-20140602) was deposited at School of Pharmacy, Hainan 
Medical University. 
 
Extracts Preparation 
 
AOF (1000g) was broken by knock and separated to the seed part (628g) and the shell part (365g). The seed part of AOF was 
extracted with 95% ethanol under reflux, and then concentrated under reduced pressure to yield an ethanolic extract (50.4g). The 
ethanolic extract (40g) wad submitted to column chromatography over HP-20 macroporous resin eluted with 50% ethanol and 90% 
ethanol respectively. The 90% ethanol elution was concentrated under reduced pressure to yield brown oil (SREAO, 12.1g). 
The shell part of AOF was extracted with 95% ethanol and yielded an extraction (30.7g). The 25g of extract was treated with 
HP-20 macroporous resin as the same process of seed. Then the 90% ethanol elution of shell was concentrated under reduced 
pressure and obtained a reddish brown extract (DREAO, 6.7g).  
 
Chromatography Analysis 
 
The nootkatone and yakuchinone A were the main compounds of sesquiterpenes and diphenylheptanes in fruit. So the content 
of nootkatone and yakuchinone A in the SREAO and DREAO were detected by HPLC-UV. The analysis was done as the previous 
method (Li YH et al., 2013) with minor modify. Briefly the LC analysis was carried out on a Shimadzu LC-20A HPLC system 
(Shimadzu Corp., Tokyo, Japan).  A Phenomenex Luna C18 column (250 mm × 4.6 mm, 5μm) was employed and the column 
temperature was maintained at 30°C. The mobile phase was composed of A (water ) and B ( acetonitrile ) using a gradient elution: 
70% A from 0 to 15.0 min, 70-56% from 15.0 to 45.0min, 56% from 45.0 to 55.0min , 56-30% from 55.0 to 60.0min with a flow rate 
set at 1.0 mL/min. The injection volume was 5 μL. The Labsolution Analyst software packages were used to control the LC system.  
For the analysis, 25mg of SREAO and DREAO were dissolved with 10ml of acetonitrile in an ultrasonic bath for 10 min. All 
solutions were filtered through a 0.45μm membrane filter before injection. 
 
Diuretic and Anti-Diuretic Activity  
 
This study was conducted in accordance with the Experimental Animal Administration regulations issue by the State 
Committee of Science and Technology of the People’s Republic of China. All procedures described here had prior approval from the 
Institutional Animal Care and Use Committee at the Hainan Medical University (Haikou, China).Male Wistar rats weighing 250-300 
g were housed in standard conditions with free access to commercial chow and water. Animals were kept at a room temperature of 
22±2°C with a light/dark cycle of 12/12 h. the experiments were conducted in accordance with internationally accepted standard 
procedures for the animal use. 
The diuretic and anti-diuretic activity was determined according to the previous method (Kau et al., 1984) with some 
modifications. Brief, rats after overnight fasting and water ad libitum were divided into eight groups (n=6). Before treatment, all 
animals received isotonic saline (0.9% NaCl) with an oral dose of 5% body weight to impose a uniform water load. Thirty minutes 
later, the SREAO and DREAO extract were orally administered to the animals at doses of 100,200,400mg/kg BW respectively. 
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Negative control group received the same amount of distilled water and positive control received 10mg/kg BW of furosemide. Each 
rat was individually placed in a metabolic cage, and the cumulative urine output was determined at hourly intervals for 6h. The 
electrolytes (Na+, K+ and Cl-) concentrations and pH were determined in the 6h urine samples from the rats. 
 
Analytical Procedures 
  
The urine Na+, K+ and Cl- concentrations were measured using flame photometry. The concentrations of Cl- were quantified by 
argentimetry (titration). The pH of fresh urine samples was determined using a pH-meter. 
 
Statistical Analysis 
 
The results were expressed as the mean ± S.E. (standard error of mean). The statistical differences were performed by 
analysis of variance (ANOVA) followed by Student’s t-test for multiple comparisons. A p value less than 0.05 were considered 
statistically significant. 
 
Analysis of Active Fractions 
 
The sample solution was prepared by dissolving 1.0 mg of fraction C in 10mL of methanol. UHPLC-DAD-Q-TOF-MS/MS 
analysis was performed with a Waters Acquity™ Ultra Performance LC system (Waters Corp., Milford, MA) equipped with HSS T3 
column (2.1 mm×100mm, 1.8 μm, UK). Mobile phase A was water with 0.1% formic acid, while mobile phase B was acetonitrile 
modified by the addition of 0.1% formic acid. A solvent gradient system was used: 95-70% A from 0 to 3.0 min, 70–45% A for 3.0
–13.0 min, 45–5% A for 13.0–16.0 min, 5.0% A for 16.0–18.0 min, and 5.0–95% A for 18.0–20.0 min. The flow rate was 0.4 
ml/min. The analytical column and auto-sampler were maintained at temperature of 35 °C and 4 °C, respectively. Every 2 μl sample 
solution was injected for each run. 
 
Results and Discussion 
Phytochemical Analysis 
 
The phytochemical analysis of two extracts showed that the contents of nootkatone in SREAO and DREAO were 18.2% and 
5.34%, respectively. While the contents of yakuchinone A in SREAO and DREAO were 0.81% and 21.9%. 
 
Urinary Excretion Volume 
 
The data obtained after the oral administration of SREAO and DREAO are shown in Fig.1 significant decreasing in urinary 
excretion was observed for 200 mg/kg and 400mg/kg of SREAO for 1h (45.23% and 47.12%, p < 0.001), as well as for 3, 4h of 200 
mg/kg (30.53% and 29.36%, p < 0.01). While the 400mg/kg dose of SREAO produced a remarkable increase in the urinary volume 
excretion at 5 and 6h (69.64% and 71.74% respectively, p < 0.01). From the result, it shows that the SREAO display a short-time 
anti-diuretic activity after the SREAO administrated, then the anti-diuretic activity decreased with the time extend, especially for 5 
and 6h of the 400mg/kg administrated, a significant diuretic activity was observed. 
 
Electrolyte Excretion  
 
Table 1 shows the results of electrolyte excretion after oral administration of SREAO and DREAO. The 400mg/kg doses of 
SREAO showed are remarkable increase for urine volume and electrolyte excretion of K+ (12.4%, P<0.01 compared with the control 
group). The Na+/K+ ratio was also remarkable decreased by the 400mg/kg doses of SREAO (22.7%, P<0.05 compared with the 
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control group). The 100mg/kg doses of SREAO show significant increase of urine electrolyte excretion K+, but the results did not 
reach statistical significance. The 200 and 400 mg/kg doses of DREAO produced a slight decrease in Na+ (7.17% and 
7.48%,respectively) and increase in K+ excretion(8.86% and 9.91%, respectively), which was in agreement with the total urine 
output. 
The pH values of the urine treated with SREAO and DREAO were higher than in the control group, but the results did not 
reached statistical significance. 
 
 
Table 1: Effect of acute oral administration of SREAO, DREAO, and furosemide on urinary electrolyte excretion 
Group pH 
Urine electrolytr concentration Saluretic indexa 
Na+/K+ 
Na+(mmol/L) K+(mmol/L) Cl-(mmol/L) Na+ K+ Cl- 
Control 6.12±0.21 45.21±1.16 25.73±1.83 142.16±9.45 1.00 1.00  1.00  1.76±0.16 
Furosemide (10mg/kg) 6.33±0.19 67.14±11.33* 32.41±3.54* 132.35±32.75 1.49  1.26  0.93  2.08±0.34 
SREAO (100mg/kg) 
6.15±0.14 
44.83±16.37 30.76±16.08 149.02±32.26 0.99  1.20  1.05  1.61±1.34 
SREAO (200mg/kg) 
6.39±0.08 
40.11±4.97 25.25±3.01 139.22±37.82 0.89  1.13  0.98  1.65±0.35 
SREAO (400mg/kg) 
6.25±0.24 
41.05±4.60 28.95±1.23** 113.73±31.45 0.91  0.98  0.80  1.33±0.29* 
DREAO (100mg/kg) 
6.26±0.13 
43.38±5.75 25.59±5.45 103.14±35.58 0.96  0.99  0.73  1.77±0.56 
DREAO (200mg/kg) 
6.19±0.08 
41.97±2.81 28.01±5.15 129.41±55.10 0.93  1.09  0.91  1.50±0.15 
DREAO (400mg/kg) 
6.29±0.23 
41.83±6.19 28.28±3.58 132.15±49.36 0.93  1.10  0.93  1.49±0.20 
 
Chemical Analysis 
 
Initial UHPLC-DAD-Q-TOF-MS scanning of SREAO suggested that during the positive ion mode, the major peaks elicited 
good responses. Further experiments were therefore carried out in the positive mode. A typical BPI chromatogram was shown in Fig. 
2. Through extensive MS and MS/MS analysis, three compounds (1–3) were identified in the fraction, and nootkatone was confirmed 
by comparing their retention times and MS data with those of the authentic compounds. 
 
Table 2: Chromatographic and MS data of compounds identified in SREAO 
No. tR (min) Compound [M+H]+(m/z) Formula Product ions (relative abundance %) 
1 6.31 Oxyphyllol A 221.1561 C15H24O MS2[221]: 221(18), 219(100), 203(6), 163(9) 
2 8.15 Oxyphyllol B 235.1710 C15H22O2 MS2[235]: 235(100), 217(8), 177(16) 
3 14.74 Nootkatone 219.1743 C15H22O MS2[219]: 219(100), 201(5),163(8) 
The retention times of compounds 1, 2 and 3 were 6.31, 8.15, and 14.74 min, respectively. Compound 1 gave a [M+H]+ at m/z 
221.1561 (C15H24O). Fragment ions at 219.1737, 203.1454 and 163.1130 derived from the loss of 2H, H2O and H2O + C3H4, 
respectively. Major MS2 ions at 219.1737 resulted from electron rearrangement of and formed a stable pentagon ring, ion at 163.1130  
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Figure 1: Time courses of diuretic and anti-diuretic activities of single oral doses (100, 200, 400mg/kg) of SREAO(A), (100, 200 and 
400mg/kg) of DREAO(B), and the reference drug, furosemide (10mg/kg). The volume of excrete d urine was measured at 1,2,3,4,5 
and 6h after administration. The cumulative values are reported as the mean ± S.E. for6 rats in each group.**P<0.01, 
***P<0.001compared with the controls using Student's t-test for anti-diuretic activity. ##P<0.01 compared with the controls using 
Student's t-test for diuretic activity 
 
 
 
 
Figure 2: The BPI chromatogram of the SREAO fraction (A), and the MS2 spectrums for Oxyphyllol A (B), Oxyphyllol B (C) and 
Nootkatone (D). 
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Figure 3: Fragmentation pathway of Oxyphyllol A (A), Oxyphyllol B (B) and Nootkatone (C) 
 
corresponded to the bicyclic moiety. By matching the MS and MS2 data with available reference (Xu et al., 2009), it was tentatively 
assigned as Oxyphyllol A, the possible fragmentation pattern was shown in Fig. 3. 
Compound 2 showed an accurate mass of [M+H]+ ion at m/z 235.1710 corresponding to the molecular formula C15H22O2. In 
the MS/MS spectrum, signals for ion at m/z 217.1604 [M+H−18]+ via the loss of H2O and the characteristic ion at 177.1284 
[M+H-18-40]+ that indicated loss of a isopropyl, suggesting compound 2 contain a hydroxyl and a isopropyl. According to its MS 
data and LC retention time with literature (Morikawa et al., 2002), compound 2 was deduced as Oxyphyllol B and the possible 
fragmentation pattern was shown in Fig.3. 
Compound 3 was deduced as nootkatone compared with the authentic compound and its MS data. The possible fragmentation pattern 
of compounds 3 was shown in Fig.3. 
From above results, we can infer that the main constituents of SREAO were sesquiterpene compounds. But beside these three 
compounds, there are still some peaks were unknown in the UPLC-QTOFMS chromatogram. It is possible that unknown 
anti-diuretic constituents are also present in SREAO fraction. The overall result indicated that the significant anti-diuretic activity of 
SREAO could be attributed to the presence of multiple compounds, but efforts are still needed to clarify exactly the active principles 
of the SREAO fraction. The results have provided evidence for further development and utilization of SREAO. 
 
Conclusion 
 
This study examined the diuretic and anti-diuretic activities of multiple doses of SREAO and DREAO in rats. The results 
showed the 200mg/kg and 400mg/kg doses of SREAO produced significant anti-diuretic activity within 1h (45.23% and 47.12%, 
respectively), and the urine volume increased with time extending, at 6h the 400mg/kg doses of SREAO produced a significant 
diuretic activity (71.74%). The 6h of electrolyte excretion show that 400mg/kg doses of SREAO can increase the K+ excretion 
consistent with the urine volume excretion. This result indicated that the SREAO possessed dual effect on renal function, including 
inhibiting diuretic activity at initial stage (1h) and promoting diuretic activity at later stage (5h and 6h), which is different than other 
diuretics in natural medicine. For the diuretic activity of DREAO, it did not present an obvious effect on the urine volume and 
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electrolyte excretion. This indicated that the SREAO fraction was the active ingredient of Alpinia oxyphylla anti-diuretic activity. 
And the phytochemical study of SREAO revealed that the sesquiterpenes were the main compounds. So the sesquiterpene 
compounds contributed to the anti-diuretic active of Alpinia oxyphylla. 
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